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Abstract: Whether vitamin C from wholefoods has equivalent bioavailability to a purified 
supplement remains unclear. We have previously showed that kiwifruit provided 
significantly higher serum and tissue ascorbate levels than synthetic vitamin C in a 
genetically vitamin C-deficient mouse model, suggesting a synergistic activity of the whole 
fruit. To determine if these results are translatable to humans, we carried out a randomized 
human study comparing the bioavailability of vitamin C from kiwifruit with that of a 
vitamin C tablet of equivalent dosage. Thirty-six young non-smoking adult males were 
randomized to receive either half a gold kiwifruit (Actinidia Chinensis var. Hort 16A)  
per day or a comparable vitamin C dose (50 mg) in a chewable tablet for   
six weeks. Ascorbate was monitored weekly in fasting venous blood and in urine, semen, 
leukocytes, and skeletal muscle (vastus lateralis) pre- and post-intervention. Dietary intake 
of vitamin C was monitored using seven day food and beverage records. Participant 
ascorbate levels increased in plasma (P < 0.001), urine (P < 0.05), mononuclear cells   
(P < 0.01), neutrophils (P < 0.01) and muscle tissue (P < 0.001) post intervention. There 
were no significant differences in vitamin C bioavailability between the two intervention 
groups in any of the fluid, cell or tissue samples tested. Overall, our study showed 
comparable bioavailability of synthetic and kiwifruit-derived vitamin C. 
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1. Introduction 
Vitamin C (ascorbate) is an essential water-soluble micronutrient that is obtained through the diet 
primarily from fruits and vegetables [1]. The bioavailability of dietary vitamin C represents the 
proportion absorbed by the intestines and available for metabolic processes within the body. Vitamin C 
is actively transported into the body via two sodium-dependent vitamin C transporters, SVCT1 and 
SVCT2, which exhibit different tissue distributions and uptake kinetics [2,3]. SVCT1 is expressed in 
epithelial tissue and is primarily responsible for intestinal uptake and renal reabsorption of vitamin C, 
the latter maintaining whole body homeostasis [3]. SVCT2 is expressed in specialized and metabolically 
active tissues and is required for delivery of vitamin C to tissues with a high demand for the vitamin 
either for enzymatic reactions [4] and/or to help protect these tissues from oxidative stress [3]. 
Kiwifruit are rich in vitamin C [5] and we have previously used a genetically vitamin C-deficient 
mouse model (the Gulo mouse) to investigate the comparative bioavailability of synthetic versus 
kiwifruit-derived vitamin C [6]. Interestingly, we found that kiwifruit gel provided higher serum, 
leukocyte, heart, liver and kidney levels of ascorbate than equivalent amounts of purified vitamin C, 
suggesting a synergistic activity of the whole fruit in this model. Although synthetic and food-derived 
vitamin C are chemically identical, the bioavailability of vitamin C could potentially be affected by the 
numerous micronutrients and phytochemicals with antioxidant properties that are present in fruits and 
vegetables [7,8]. For example, kiwifruit contain reasonable amounts of vitamin E [9], which has been 
shown to spare vitamin C in an animal model [10]. Kiwifruit also contain numerous different 
flavonoids [9,11], some of which can inhibit the in vitro oxidation of vitamin C via direct scavenging 
of free radicals and/or chelation of redox-active metal ions [7,8]. 
To determine if the results of our animal study [6] are translatable to humans, we carried out a 
randomized human study comparing the bioavailability of vitamin C from gold kiwifruit   
(Actinidia Chinensis var. Hort 16A) with a tablet of equivalent dosage. We have previously shown that 
consumption of half a gold kiwifruit per day results in a significant increase in plasma ascorbate in 
individuals with low initial levels (<23 µmol/L) [12]. For this study, we chose a dose of half a kiwifruit per 
day and the equivalent 50 mg/day vitamin C since this dose lies on the steeply rising portion of the 
sigmoidal plasma bioavailability curve [13]. This enhances the likelihood of detecting a difference between 
the two interventions compared with doses >100 mg/day where plasma saturation is approached [13]. 
Several previous studies have tested the comparative bioavailability of synthetic versus  
food-derived vitamin C utilizing plasma and/or urine levels [14–18]. However, only one has 
investigated the comparative bioavailability of vitamin C in leukocytes [19]. Therefore, in addition to 
plasma and urine, we have monitored the bioavailability of vitamin C in peripheral blood mononuclear 
cells and neutrophils, seminal fluid and skeletal muscle tissue [20] before and after the six week 
intervention. We also monitored the participants’ dietary intake of vitamin C using seven day food and 
beverage records. Nutrients 2013, 5  3686 
 
2. Study Design and Methods 
2.1. Participants 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki and 
all procedures involving human participants were approved by the Upper South Regional Ethics 
Committee (#URA/11/02/003). The study was registered with the Australian New Zealand Clinical 
Trials Registry (#ACTRN12611000162910). 
Non-smoking males aged 18–35 years from local tertiary institutes were screened to ascertain their 
eligibility for the study. Exclusion criteria included recent smoker (within previous year), 
allergy/intolerance to kiwifruit, taking vitamin C-containing supplements (within past three months), 
taking prescription medication (within past three months), excessive alcohol consumption   
(>21 standard drinks/week), high fruit and vegetable consumption (>5 servings per day), diabetes 
mellitus, bleeding disorders, and fainting due to fear of needles. Anthropometric measurements were 
carried out to determine body mass index (BMI) and a fasting venous blood sample was drawn to 
determine plasma ascorbate levels as described below. 
Sample size calculations indicated that at 80% power and alpha = 0.05, a sample size of   
15 participants per intervention group would detect a minimum difference of 10 µmol/L ascorbate as 
determined using data derived from our previous vitamin C bioavailability study [12]. To allow for 
potential withdrawal during the study, 36 non-smoking participants (18 per group) with below average 
plasma ascorbate levels were enrolled for the study and provided written informed consent. 
2.2. Study Design 
The study employed a parallel arms design and the participants were randomized into a 50 mg 
vitamin C per day group or a half kiwifruit per day group using a random numbers chart. A parallel arms 
rather than cross-over study design was chosen to avoid potential confounding by kiwifruit-derived 
constituents, e.g., vitamin E, which may not wash out prior to the vitamin C supplement phase of a 
cross-over study. A lead-in phase of five weeks allowed the participants time to control their dietary 
vitamin C intake by eliminating juice and substituting high vitamin C foods, e.g., citrus and kiwifruit, 
with low vitamin C foods, e.g., apples and bananas (guidelines were provided as to the vitamin C 
content of common foods). This was followed by an intervention phase of six weeks and a washout 
phase of four weeks (Figure 1). Fasting venous blood samples were drawn weekly to monitor plasma 
ascorbate levels. Twenty four hour urine, semen, and leukocyte samples were collected at week five 
(baseline), week 11 (post-intervention) and week 15 (post-washout). Muscle biopsies were carried out 
at baseline and post-intervention. Participants also completed four seven-day food and beverage 
records (at the beginning of the study, pre- and post-intervention and post-washout). 
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Figure 1. Parallel groups study design. * Weekly plasma samples; ** urine, semen and 
leukocyte samples; *** urine, semen, leukocyte and skeletal muscle samples. 
 
2.3. Interventions 
Chewable orange-flavored vitamin C tablets were provided by Tishcon Corp., Westbury, NY, USA. 
Analysis of the tablets indicated that they contained 52 mg of vitamin C per tablet. Participants in the 
vitamin C tablet arm of the study were asked to consume one tablet per day. 
Gold kiwifruit (Actinidia chinensis var. Hort. 16A) were provided by Zespri International Ltd., 
Mount Maunganui, New Zealand, and were stored at ≤4 °C. The vitamin C content of the kiwifruit 
was monitored by HPLC with electrochemical detection [12] and indicated that the kiwifruit flesh 
contained 116 ± 10 mg vitamin C per 100 g (mean ± SD, n = 5); this value did not change during cold 
storage of the fruit. Participants in the kiwifruit arm were asked to consume half a fresh kiwifruit daily, 
not including the skin. Therefore, the actual amount of vitamin C consumed was estimated to be  
~53 mg per half a kiwifruit. 
2.4. Sample Collection and Processing 
2.4.1. Plasma, Urine and Semen 
Peripheral blood was collected into 5 mL K3-EDTA vacutainer tubes and plasma was isolated by 
centrifugation at 4 °C. Urine was collected over 24 h into pre-weighed collection bottles containing 
K2-EDTA. Semen was collected into pre-weighed collection containers containing K2-EDTA and kept 
cold until processed. The plasma, urine and semen samples were extracted with perchloric acid 
containing DTPA, as described previously [12], prior to storage at −80 °C until HPLC analysis. 
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2.4.2. Mononuclear Leukocytes and Neutrophils 
White blood cells were purified from heparinized whole blood as described previously [20], the cell 
pellets counted and extracted with perchloric acid containing DTPA, and the supernatants stored at  
−80 °C until HPLC analysis. 
2.4.3. Skeletal Muscle Tissue 
A small piece of tissue (~14 mg) was removed from the vastus lateralis using a Quick-Core biopsy 
needle (14 gauge, 6 cm long with a 20 mm throw, from Cook Medical Inc., Bloomington, IN, USA), 
and processed as described previously [20], extracted with perchloric acid containing DTPA, and 
stored at −80 °C until HPLC analysis. 
2.5. Analysis of Vitamin C by HPLC 
The ascorbate content of the kiwifruit, plasma, urine, semen, leukocytes and muscle tissue was 
analyzed using reverse-phase HPLC with electrochemical detection as described previously [12]. 
Briefly, samples were separated on a Synergi 4 µ Hydro-RP 80A 150 × 4.6 mm column (Phenomenex 
NZ Ltd., Auckland, New Zealand) using a Waters 600 solvent delivery system with a Hitachi L-2200 
refrigerated autosampler and an ESA Coulochem II electrochemical detector (+200 mV electrode 
potential and 20 µA sensitivity). The mobile phase comprised 80 mM sodium acetate buffer, pH 4.8, 
containing DTPA (0.54 mmol/L) and freshly added paired-ion reagent n-octylamine (1 µmol/L), 
delivered at a flow rate of 1.2 mL/min. A standard curve of sodium-L-ascorbate, standardized 
spectrophotometrically, was freshly prepared for each HPLC run in 77 mmol/L HPLC-grade 
perchloric acid containing DTPA (100 µmol/L). 
2.6. Analysis of Food and Beverage Records 
The vitamin C content of the food and beverage dietary records was estimated using Diet Cruncher 
software [21], and the New Zealand FOODfiles Food Composition Database (2006) as described 
previously [12]. 
2.7. Statistical Analysis 
Data is represented as mean ± SD for group characteristics and mean ± SEM for comparison of 
group means. The differences between paired and unpaired data were determined by two-tailed 
Students’s t-tests and P values ≤ 0.05 were considered significant. Analysis of variance with Fisher 
pairwise multiple comparison procedure was carried out using SigmaStat software [22]. 
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3. Results 
3.1. Participant Characteristics 
One hundred and thirty four non-smoking individuals were screened and their fasting plasma 
ascorbate concentrations determined. The average ± SD plasma ascorbate concentration for these 
individuals was 48 ± 16 µmol/L (Table 1). Thirty six of the individuals with below average plasma 
ascorbate levels, who also satisfied the other inclusion criteria, were enrolled in the study and 
randomized into the vitamin C tablet group or the half kiwifruit per day group. The average ± SD 
fasting plasma ascorbate levels of the enrolled groups were 31 ± 11 µM and 34 ± 10 µM, with a range 
of 3 µM to 44 µM (Table 1). There were no significant differences between the two groups. 
Table 1. Characteristics of individuals screened and enrolled in the study. 
 
Screened 
a 
(n = 134) 
Vitamin C Group 
a 
(n = 18) 
Kiwifruit Group 
a 
(n = 18) 
Age (years)  21 ± 3  21 ± 3  22 ± 4 
Weight (kg)  81 ± 16  84 ± 19  89 ± 23 
Height (cm)  182 ± 7  181 ± 7  181 ± 7 
BMI (kg/m
2)  24 ± 4  26 ± 5  27 ± 6 * 
Ascorbate (µmol/L)  48 ± 16  31 ± 11 **  34 ± 10 ** 
a Data represent mean ± SD; * P < 0.05, ** P < 0.001 for unpaired t-test of intervention groups versus 
screened group. There were no significant differences between the intervention groups. 
3.2. Dietary Intake of Vitamin C 
Analysis of the food and beverage records indicated a vitamin C intake of ~30 mg/day at baseline 
(Table 2). Addition of the vitamin C tablet or half a kiwifruit per day to the daily diet of the two groups 
resulted in an increase in vitamin C intake, with both groups approaching ~75 mg (Table 2), and no 
difference between the two groups (P = 0.512). Following four weeks washout, the vitamin C intake 
had returned to baseline levels. 
Table 2. Change in vitamin C intake and ascorbate concentration in body fluids, cells and 
tissue following supplementation with 50 mg vitamin C or half a kiwifruit per day for  
six weeks. 
 
Vitamin C group 
a 
(50 mg/day) 
Kiwifruit group 
a 
(half/day) 
Between group
  Baseline  Intervention Washout  Baseline  Intervention Washout 
Intervention 
P value 
b 
Intake (mg/day)  31.2 ± 3.1  76.7 ± 2.6 ***  29.1 ± 2.9  28.6 ± 3.1  73.4 ± 4.2 *** 31.4 ± 5.1  0.512 
Plasma (µmol/L)  23.5 ± 2.5  51.3 ± 3.5 ***  34.3 ± 4.4 *  22.7 ± 2.5  45.5 ± 2.5 *** 30.5 ± 3.1  0.860 
Urine (µmol/24 h)  42.8 ± 9.2  104.2 ± 27.6 *  59.5 ± 19.9  32.3 ± 8.1  70.5 ± 17.0 *  64.7 ± 29.8  0.503 
Semen (µmol/L)  284.8 ±27.0  321.0 ± 33.3  264.4 ± 31.1 * 326.3 ± 47.5 378.8 ± 42.7  237.7 ± 19.6 *   0.676 
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Table 2. Cont. 
Mononuclear cells (nmol/10
8 cells)  38.7 ± 6.2  84.5 ± 6.3 *** 78.5 ± 4.3 ** 60.5 ± 6.1 90.9 ± 6.1 **  75.2 ± 5.2  0.227 
Neutrophils  
(nmol/10
8 cells) 
21.9 ± 3.1  39.6 ± 3.8 **  24.9 ± 2.1  13.7 ± 2.4 30.4 ± 2.5 ***  24.8 ± 1.7 *** 0.798 
Skeletal muscle (nmol/g)  14.5 ± 2.0  61.3 ± 3.5 *** nd  15.1 ± 2.5 52.8 ± 5.0 ***  nd  0.429 
a Data represent mean ± SEM; 
b P values were determined by unpaired t-test of vitamin C group versus kiwifruit group post-intervention following 
subtraction of baseline values; * P < 0.05 and ** P < 0.01 and *** P < 0.001 for paired t-test of intervention versus baseline. nd = not determined. 
3.3. Vitamin C Status of Plasma, Urine and Semen 
Plasma ascorbate levels increased significantly during the six week intervention phase, from   
~23 µmol/L to a maximum of ~50 µmol/L (Table 2). There were no significant differences between 
the two groups during this period or during the four week washout phase (Figure 2). Similarly, there 
were no significant differences between the two treatment groups for either urinary ascorbate excretion  
(P = 0.503) or seminal ascorbate levels (P = 0.676) (Table 2). 
Figure 2. Plasma ascorbate concentrations in vitamin C group (50 mg/day, ●) and kiwifruit 
group (0.5/day, ○). Data represent mean ± SEM. Two way analysis of variance with Fisher 
pairwise multiple comparison procedure indicated a significant increase in plasma 
ascorbate from one week post-intervention (week 6) onwards, but no significant difference 
between the two interventions. 
 
3.4. Vitamin C Status of Leukocytes and Skeletal Muscle Tissue 
The ascorbate levels in mononuclear cells and neutrophils in both intervention groups increased 
following the six week intervention (Table 2), but there were no differences between the two 
interventions (P = 0.798). The baseline skeletal muscle tissue ascorbate levels were ~15 nmoL/g wet 
weight, and following intervention there were 3.5- to 4-fold increases in tissue ascorbate levels in both 
treatment groups (Table 2). Once again, there were no significant differences between the two 
intervention groups (P = 0.429). Nutrients 2013, 5  3691 
 
4. Discussion 
In direct contrast to our previous Gulo knockout mouse study, which showed clear differences in 
comparative vitamin C bioavailability [6], this investigation has shown no differences in the   
steady-state bioavailability of synthetic versus kiwifruit-derived vitamin C in plasma, semen, 
peripheral blood leukocytes and skeletal muscle of humans. Other comparative bioavailability studies 
in guinea pigs have shown similar results to our animal study [23–27]. Enhanced uptake of vitamin C 
into specific organs of guinea pigs (e.g., adrenals and spleen) was observed when administered with 
flavonoid-rich juices/extracts or purified plant flavonoids [23–27], although comparable vitamin C 
accumulation was observed in some organs (e.g., liver) in several studies [23–25,28], suggesting either 
tissue specific differences or effects of differences in study design. 
In agreement with our current human study, others have shown little difference in steady-state 
plasma and/or urine bioavailability of synthetic vitamin C and that found in different fruits, fruit juices 
and vegetables [14–19]. Only one previous study has investigated the comparative bioavailability of 
synthetic versus natural vitamin C in leukocytes [19]. Although neutrophils express SVCT2 [29], when 
their respiratory burst is activated they primarily transport the oxidized form of ascorbate 
(dehydroascorbic acid) via the glucose transporters GLUT 1 and GLUT 3, followed by intracellular 
reduction [30]. In support of our observations with neutrophils and mononuclear cells, Pelletier et al. [19] 
found no difference in leukocyte ascorbate uptake between synthetic vitamin C (in the presence or 
absence of rutin) and that from orange juice. Interestingly, an in vitro study showed that the flavonoids 
myricetin and quercitin inhibited the uptake of both ascorbate and dehydroascorbic acid into 
monocytic (HL-60 and U937) and lymphocytic (Jurkat) cells [31]. Whether this occurs in vivo is, 
however, uncertain due to the low plasma bioavailability of flavonoids [32]. 
Although leukocyte ascorbate status is often used as an indicator of whole body status, whether this is 
an accurate model for other tissues and organs is uncertain. This premise is supported by our animal 
study which indicated that different organs exhibited maximal uptake at varying doses of vitamin C [6]. 
Therefore, we also investigated the previously unreported effects of synthetic versus natural vitamin C 
on skeletal muscle ascorbate status. Ascorbate is transported into muscle cells via SVCT2 [33,34]. In 
our study muscle tissue exhibited a greater relative uptake of ascorbate than leukocytes, however, there 
was again no difference in bioavailability between the synthetic and fruit-derived vitamin C. 
We also investigated seminal fluid ascorbate status. Although the baseline seminal fluid ascorbate 
was lower than vitamin C replete and healthy non-smoking men [35–37], little change was observed 
with the low dose vitamin C tablet or half kiwifruit per day dose. Early studies have shown that 
vitamin C intakes of up to 250 mg/day are required to return depleted seminal ascorbate to normal  
levels [35,36,38], indicating that higher intakes of vitamin C, e.g., those that result in plasma 
saturation, are required to increase seminal fluid levels [39]. 
5. Conclusions 
Numerous animal studies have shown differences between the tissue bioavailability of synthetic and 
natural or flavonoid-rich vitamin C. However, more evidence is accumulating to indicate that this is 
not the case in humans. Our current human study showed no difference in bioavailability to plasma, Nutrients 2013, 5  3692 
 
semen, peripheral blood leukocytes and skeletal muscle of kiwifruit-derived vitamin C compared with 
a chewable vitamin C tablet of equivalent dosage. Thus, other nutrients and phytochemicals present in 
kiwifruit appear to be neither enhancing nor inhibiting the uptake of vitamin C from the whole fruit. 
However, vitamin C is known to enhance the bioavailability of other nutrients, such as non-heme  
iron [40,41], and kiwifruit also contain numerous micronutrients and phytochemicals which will 
undoubtedly confer considerable health benefits in addition to the positive effects of the high levels of 
vitamin C also delivered by this fruit [42]. 
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